These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38058168)

  • 1. RNA aptamer-mediated gene therapy of prostate cancer: lessons from the past and future directions.
    Arese M; Mahmoudian M; Bussolino F
    Expert Opin Drug Deliv; 2023; 20(11):1609-1621. PubMed ID: 38058168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of aptamers in prostate cancer: A systematic review of theranostic applications.
    Campos-Fernández E; Oliveira Alqualo N; Moura Garcia LC; Coutinho Horácio Alves C; Ferreira Arantes Vieira TD; Caixeta Moreira D; Alonso-Goulart V
    Clin Biochem; 2021 Jul; 93():9-25. PubMed ID: 33794195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo.
    Hao Z; Fan W; Hao J; Wu X; Zeng GQ; Zhang LJ; Nie SF; Wang XD
    Drug Deliv; 2016; 23(3):874-81. PubMed ID: 24892627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy.
    Wu X; Ding B; Gao J; Wang H; Fan W; Wang X; Zhang W; Wang X; Ye L; Zhang M; Ding X; Liu J; Zhu Q; Gao S
    Int J Nanomedicine; 2011; 6():1747-56. PubMed ID: 21980237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamers as Theragnostic Tools in Prostate Cancer.
    Cruz-Hernández CD; Rodríguez-Martínez G; Cortés-Ramírez SA; Morales-Pacheco M; Cruz-Burgos M; Losada-García A; Reyes-Grajeda JP; González-Ramírez I; González-Covarrubias V; Camacho-Arroyo I; Cerbón M; Rodríguez-Dorantes M
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system.
    Jing P; Cao S; Xiao S; Zhang X; Ke S; Ke F; Yu X; Wang L; Wang S; Luo Y; Zhong Z
    Cancer Lett; 2016 Dec; 383(2):230-242. PubMed ID: 27721020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting prostate-specific membrane antigen for personalized therapies in prostate cancer: morphologic and molecular backgrounds and future promises.
    Santoni M; Scarpelli M; Mazzucchelli R; Lopez-Beltran A; Cheng L; Cascinu S; Montironi R
    J Biol Regul Homeost Agents; 2014; 28(4):555-63. PubMed ID: 25620167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA-Paclitaxel Conjugate.
    Lv Q; Yang J; Zhang R; Yang Z; Yang Z; Wang Y; Xu Y; He Z
    Mol Pharm; 2018 May; 15(5):1842-1852. PubMed ID: 29608845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.
    Lupold SE; Hicke BJ; Lin Y; Coffey DS
    Cancer Res; 2002 Jul; 62(14):4029-33. PubMed ID: 12124337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery.
    Leach JC; Wang A; Ye K; Jin S
    Int J Mol Sci; 2016 Mar; 17(3):380. PubMed ID: 26985893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamers and apple pies: a mini-review of PSMA aptamers and lessons from Donald S. Coffey.
    Lupold SE
    Am J Clin Exp Urol; 2018; 6(2):78-86. PubMed ID: 29666835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling.
    Rockey WM; Hernandez FJ; Huang SY; Cao S; Howell CA; Thomas GS; Liu XY; Lapteva N; Spencer DM; McNamara JO; Zou X; Chen SJ; Giangrande PH
    Nucleic Acid Ther; 2011 Oct; 21(5):299-314. PubMed ID: 22004414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
    Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research.
    Ristau BT; O'Keefe DS; Bacich DJ
    Urol Oncol; 2014 Apr; 32(3):272-9. PubMed ID: 24321253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unleashing novel horizons in advanced prostate cancer treatment: investigating the potential of prostate specific membrane antigen-targeted nanomedicine-based combination therapy.
    He M; Cao Y; Chi C; Zhao J; Chong E; Chin KXC; Tan NZV; Dmitry K; Yang G; Yang X; Hu K; Enikeev M
    Front Immunol; 2023; 14():1265751. PubMed ID: 37795091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
    Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
    Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Administration and Targeted Radiosensitization via Chemically Synthetic Aptamer-siRNA Chimeras in Human Tumor Xenografts.
    Ni X; Zhang Y; Zennami K; Castanares M; Mukherjee A; Raval RR; Zhou H; DeWeese TL; Lupold SE
    Mol Cancer Ther; 2015 Dec; 14(12):2797-804. PubMed ID: 26438155
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.